Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics
ObjectiveThis study compares the cardiovascular risk in anemic chronic kidney disease patients treated with Roxadustat versus erythropoietin stimulating agents (ESAs). It also explores the cardiovascular impact of Roxadustat.MethodsWe searched PubMed, EMBASE, Cochrane, Scopus, and Web of Science dat...
Saved in:
Main Authors: | Xiangmeng Li (Author), Shimin Jiang (Author), Xia Gu (Author), Xiaojing Liu (Author), Shunlai Shang (Author), Jiao Zhang (Author), Keying Pang (Author), Wenge Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
by: Xiaoxiao Tang, et al.
Published: (2023) -
Roxadustat on Renal Anemia with Macroinflammation: A Retrospective Cohort Study
by: Yan Tu, et al.
Published: (2024) -
Roxadustat: Not just for anemia
by: Xiaoyu Zhu, et al.
Published: (2022) -
The Chronic Kidney Disease Epidemiology Collaboration equations perform less well in an older population with type 2 diabetes than their non-diabetic counterparts
by: Shimin Jiang, et al.
Published: (2022) -
The Efficacy and Safety of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis
by: Lijun Wang, et al.
Published: (2022)